Myriam Curet is Director of NEKTAR THERAPEUTICS. Currently has a direct ownership of 27,418 shares of NKTR, which is worth approximately $32,627. The most recent transaction as insider was on Sep 18, 2023, when has been sold 4,359 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $3,007. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.4K
0% 3M change
0% 12M change
Total Value Held $32,627

Myriam Curet Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 18 2023
SELL
Open market or private sale
$3,007 $0.69 p/Share
4,359 Reduced 13.72%
27,418 Common Stock
Sep 23 2022
SELL
Open market or private sale
$13,266 $3.16 p/Share
4,198 Reduced 11.67%
31,777 Common Stock
Sep 16 2022
BUY
Grant, award, or other acquisition
-
10,200 Added 22.09%
35,975 Common Stock
Sep 22 2021
SELL
Open market or private sale
$65,164 $17.78 p/Share
3,665 Reduced 12.45%
25,775 Common Stock
Sep 22 2021
BUY
Grant, award, or other acquisition
-
10,200 Added 25.73%
29,440 Common Stock
Dec 15 2020
SELL
Open market or private sale
$27,799 $17.82 p/Share
1,560 Reduced 7.5%
19,240 Common Stock

Also insider at

ISRG
INTUITIVE SURGICAL INC Healthcare
INSP
Inspire Medical Systems, Inc. Healthcare
STXS
Stereotaxis, Inc. Healthcare
MC

Myriam Curet

Director
Sunnyvale, CA

Track Institutional and Insider Activities on NKTR

Follow NEKTAR THERAPEUTICS and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTR shares.

Notify only if

Insider Trading

Get notified when an Nektar Therapeutics insider buys or sells NKTR shares.

Notify only if

News

Receive news related to NEKTAR THERAPEUTICS

Track Activities on NKTR